Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Good buying past two days - volume not huge but good to see. Re read the RNS .. 100% match on results Results exceeded expectations 31 distributors attended launch event with excellent feedback I'm long enough here to know current SP woeful. In footballing terms ... we were probably Div one ... got knocked down to Div 2 and the Conference was looming ... I think we have steadied all that and promotion is on the horizon back to Div one and possible Championship ... IMHO - in Q1 if an RNS lands to the tune of .... 10 distributors signed ... orders of £2m placed ... pipeline in place for future orders ... then this will head north very quickly In the words of Mulder - I believe ... but we need to get out of Div 2 quickly
Welcome aboard master36 ... good luck to you. Agree with your H1 thoughts. I’ve watched this go to highs and then lows ... being on time to being very much delayed ... it’s been a rollercoaster ... however based on today I see good things ahead
Really good upbeat RNS. Not the Christmas present we wanted ... ie sales etc. However ... everything appears to be slotting into place now. With 31 distributors in attendance it shows we have interest and the medical experts have endorsed us 100% ... results exceeded expectations even. Me feeling is we still have c.3-4 months for the plan to come good. They mention visiting each distributor so I guess this is Q1. So from around March/April time I hope to the SP exceeding expectations. Been here a long time now on a paper loss. I do like the methodical approach CPT are taking and I still remain confident this will get back to c.20p level and kick on. But as others have said ... patience is the key now. Holding strong. GLA Results exceeded expectations 100% match to hospital results 31 distributors interested enough to attend the launch event Could this multi bag? Not ramping, its a question I ask myself daily, exciting times ahead I truly hope we are all rewarded.
This is not blue based on RNS and buy volumes ... our day will come folks
The results concluded that the LH and hCG2 measurements registered by myLotus achieved approximately 100% correlation with those of hospital laboratory tests carried out on blood samples. The results presented strong evidence of the product's effectivenesS This statement my friends is what I’ve been waiting for Brilliant up beat RNS ... the above says the product and tech is viable. We can now move into distributor sign ups and sales in H1. I agree patience still required. High level of buys today which is great to see. As for the SP ... don’t worry about it. H1 we are going to be rocking and rolling. IMHO.
Very true ... as you were ... nothing to see here ... keep calm and ...
... I see blue
Apologies Spindok ... mea culpa We are all hoping for good news here God speed
A fully funded company with a great product, more in the pipeline, commercialisation underway in a huge market ... Exactly They are facts Distributors already signed Manufacturing process being fixed Launch conf positive ... unless Erik is a liar But ... nothing talks like sales orders and cash
One good thing ... it’s nice to see activity on this board : ) I’m at the point where it’s either ... going to take off big time in H1 next year for the reasons you state ... or this has been a wild goose chase I’m holding onto the belief it’s the former Latest RNS talks about a transformation in 2018 ... expansion in China and EU. All that just spin and lies? Repeating myself but we need this magical RNS
Hope that proves a good buy I'm not selling as loss to high and I'm not topping up as losing faith!
No support whatsoever They will need a RNS ... silence is killing this ... unless there is nothing to say ... update needed asap
Yeah this is becoming a shambles tbh and runs the risk of being a dump
and although I agree its not huge volumes ... Erik has added c.180k shares in past few months ... again I agree its not huge ... but ... its still c £20k ... For now ... we watch and we wait
Agreed re orders. Very frustrating ... we can have endless videos etc but if nobody buys it ... the £600k order good step forward ... but there should be a fair few of those by now ... To smiths point the other day - the play here could well be to get the positive results, publicity etc and then get taken over for a decent pay day? This way an established player with distribution channels takes over the reigns? Either way I think H1 2018 could be interesting for us
https://vimeo.com/224480948 In collaboration with The British Bid
hey smith76 - I think the takeover/buy out option is a potential scenario ... if we make enough noise (still a big if) ... but lets assume we do then P&G wont want that hitting them ...! Have a good weekend and here's to a very good RNS next week!
--- sorry last sentence goy cut off --- Worth noting that AVA (US based) have developed a bracelet that tries to give a similar advanced view - this is retailing now for £199. Its available mail order only in EU from America. So if CPT can gain success in China (no competition) then enter EU they will be the only people selling such an advanced personalised kit. If we have endorsements from China on top ... then well the potential is huge. Next key steps: 1. Establish full clinical and home kit endorsement in China 2. Grow distributor network ( expect an update pre Christmas) 3. Build sales and full scale commercials 4. EU approvals The issue has been we are way off our original timings and confidence has been lost. As ever DYOR etc etc ... just my opinion but I think H1 2018 is the time when this will take off
Though numerous women become pregnant without difficulty, many others plan their pregnancies, often using urine-based tests that are designed to tell them when they are at their most fertile. These work for the average woman but, for a sizeable minority, they do not. Research has shown that 30 per cent of women with unexplained infertility issues have low levels of the luteinising hormone associated with ovulation. This does not mean they cannot have children. But it does mean off-the-shelf fertility testing kits do not work for them. Concepta has developed the first kit – MyLotus – to tell women exactly what their luteinising hormone levels are, even if they are lower (or higher) than the norm. Women simply perform a urine test at home and place the swab in a hand-held meter, which provides instant and highly accurate readings. Not only does the meter provide detailed, personalised information, but Concepta has also developed easier-to-use urine sampling equipment to make the whole process as simple as possible. The procedure can be repeated over days or months, telling women when they are most likely to become pregnant. There is also an app, that allows users to create a diary of their hormonal cycle, useful both for women and their doctors, if they ultimately resort to medical intervention. The meter even tells women if they have already become pregnant, again with ease and reliability. Concepta’s testing kit and app have been approved in China and the firm is expected to begin selling its products there this year. Meanwhile, plans for Europe are well advanced. The company, which is based in Sharnbrook, Bedfordshire, is developing a manufacturing site in Yorkshire to produce the meters and testing kits in volume. The meters are expected to go on sale for between £250 and £300 and Concepta believes that demand should run into several million, growing steadily as the brand becomes more established. The group is also working on related concepts, such as stress kits, which both men and women could use to measure their stress levels. People trying for a baby often experience high levels of stress, which can affect ovulation in women and sperm quality in men. Easy-to-use kits could show couples when and if stress is affecting fertility, allowing them to seek treatment at an early stage. Such kits could also find a market outside of fertility treatment, given the increasing prevalence of stress-related disease. Henau and his senior colleagues have decades of experience in the fertility industry, having worked on the market-leading ovulation and pregnancy testing kit, Clearblue, now owned by Procter & Gamble. Worth noting that AVA (US based) have developed a bracelet that tries to give a similar advanced view - this is retailing now for £199. Its available mail order only in EU from America. So if CPT can gain success in China (no competition) then enter EU they will be the on
Do you really think we would invest if we didn’t know? Plenty of articles etc available When I have a spare min will post some links All of CPT team have worked with or for the major players and understand their tech and how to improve/leverage it and gain advantage principally around personalisation and not generic test results. AVA developing a similar concept